Hyundai ADM Bio Inc. (KOSDAQ:187660)
South Korea · Delayed Price · Currency is KRW 8,790.00
0.00 (0.00%)
At close: Feb 19, 2026
Hyundai ADM Bio Market Cap
Hyundai ADM Bio has a market cap or net worth of 508.2 billion as of February 20, 2026. Its market cap has increased by 369.61% in one year.
Market Cap
508.20B
Enterprise Value
511.45B
Revenue
9.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,790.00
Market Cap Chart
Since June 3, 2021, Hyundai ADM Bio's market cap has increased from 215.74B to 508.20B, an increase of 135.56%. That is a compound annual growth rate of 19.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 508.20B | 289.92% |
| Dec 30, 2025 | 130.34B | 86.73% |
| Dec 30, 2024 | 69.80B | 57.99% |
| Dec 28, 2023 | 44.18B | 1.39% |
| Dec 29, 2022 | 43.58B | -66.41% |
| Dec 30, 2021 | 129.71B | -39.88% |
| Jun 3, 2021 | 215.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DreamCIS | 141.81B |
| LabGenomics | 125.09B |
| HLB bioStep | 106.69B |
| P&K Skin Research Center | 69.32B |
| C&R Research | 51.44B |
| WOOJUNG BIO | 40.48B |
| DT&CRO CO. | 35.28B |
| SLS BIO | 26.89B |